Will Brooklyn Therapeutics (BTX) Stock Come Back After a 80% Slump?

The Brooklyn Therapeutics (NYSEAMERICAN:BTX) stock had a pretty wild ride since April and this morning it has been in focus once again.

Will Brooklyn Therapeutics (BTX) Stock Come Back After a 80% Slump?

The stock is up by 5% today. However, it should be noted it had been trading at $4 a share on April 1 and from that point, it climbed to $80 a share in a matter of 5 weeks. Soon after, the Brooklyn Therapeutics stock gave up much of those gains and last week it had slumped to $13 a share.

Related:  Aimmune Therapeutics (AIMT) is soaring to fall under $20 after deal with Nestle. Here is why

There has been no fresh news with regards to the company this morning but investors need to know a bit more about the company. Brooklyn Therapeutics is involved in the development of treatment for treating patients suffering from rare diseases and cancer. The main clinical program that is being run by Brooklyn Therapeutics is called IRX 2 and it is related to the treatment for neck and head cancer.

Jack Dawkins

Finance and Tech Contributor